![Icon: Megaphone Icon: Megaphone](/content/dam/cf-pharma/gskvaccination-v2/en_US/megaphone-icon.png)
Facts About Meningococcal Disease
One out of ten patients infected will die, some in as few as 24 to 48 hours.1
Surviving patients may face long-term complications such as hearing loss, brain damage, limb loss, kidney failure, and seizures.4,5
Most meningococcal disease is attributed to serogroups A, B, C, W, and Y.2
![Meningococcal Vaccination Recommendations Meningococcal Vaccination Recommendations](/content/dam/cf-pharma/gskvaccination-v2/en_US/meningococcal-disease/meningococcal-vaccine_mobile.jpg)
![Image: Injecting meningococcal vaccine Image: Injecting meningococcal vaccine](/content/dam/cf-pharma/gskvaccination-v2/en_US/meningococcal-disease/meningococcal-vaccine.jpg)
Meningococcal Vaccination Recommendations From the Centers for Disease Control and Prevention (CDC)
Meningococcal ACWY:
- Persons 11 years of age and older, with a booster at 16 years of age; as young as 2 months of age for certain groups at increased risk6
Meningococcal B:
- Vaccination recommended for certain groups at increased risk in individuals 10 years of age and older6
- In individuals not at increased risk, MenB series for persons 16 to 23 years of age (preferably 16 to 18 years of age) on the basis of shared clinical decision-making7
Meningococcal Disease Downloadable Resources
References
- Pelton SI. Meningococcal disease awareness: clinical and epidemiological factors affecting prevention and management in adolescents. J Adolesc Health. 2010;46:S9-S15.
- McNamara LA, Blain A. Meningococcal disease. In: Roush SW, Baldy LM, Kirkconnell Hall MA, eds. Manual for the Surveillance of Vaccine-Preventable Diseases. Centers for Disease Control and Prevention; 2020. Reviewed January 5, 2022. Accessed January 30, 2024. https://www.cdc.gov/vaccines/pubs/surv-manual/chpt08-mening.html
- Meningococcal disease: signs and symptoms. Centers for Disease Control and Prevention. Revised February 7, 2022. Accessed January 30, 2024. https://www.cdc.gov/meningococcal/about/symptoms.html
- Meningitis. Mayo Clinic. Updated October 4, 2023. Accessed January 30, 2024. https://www.mayoclinic.org/diseases-conditions/meningitis/symptoms-causes/syc-20350508
- Meningococcal disease: clinical information. Centers for Disease Control and Prevention. Reviewed February 7, 2022. Accessed January 30, 2024. https://www.cdc.gov/meningococcal/clinical-info.html
- Child and adolescent immunization schedule by age, 2023. Centers for Disease Control and Prevention. Reviewed November 16, 2023. Accessed January 30, 2024. https://www.cdc.gov/vaccines/schedules/hcp/imz/child-adolescent.html
- Mbaeyi SA, Bozio CH, Duffy J, et al. Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR. 2020;69(No. RR-9):1-41. Reviewed September 24, 2020. Accessed January 30, 2024. https://www.cdc.gov/mmwr/volumes/69/rr/rr6909a1.htm?s_cid=rr6909a1_w